1.
Yee G, Wu R, Ishikawa T, Takabe K. Invasive Lobular Carcinoma Has Higher Immune Response Than Invasive Ductal Carcinoma in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers. World J Oncol [Internet]. 2025 Jan. 1 [cited 2026 Feb. 1];16(5):446-5. Available from: https://wjon.elmerpub.com/wjon/article/view/2529